| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,795 |
7,080 |
$586K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,444 |
3,177 |
$205K |
| 87428 |
|
137 |
133 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
163 |
157 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
37 |
37 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
304 |
281 |
$732.39 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
37 |
15 |
$534.26 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$422.39 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
13 |
13 |
$198.28 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$87.91 |
| 81001 |
|
16 |
16 |
$55.67 |
| 81003 |
|
26 |
26 |
$47.52 |
| 85018 |
|
14 |
14 |
$36.64 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
29 |
28 |
$0.00 |